January 27, 2021

Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders

Read More
October 20, 2020

Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer

Read More
March 20, 2020

Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders

Read More